Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Food Science|August 7, 2012
Skin extracts from 2 Italian table grapes (Italia and Palieri) inhibit tissue factor expression by human blood mononuclear cellsRosa Anna Milella, Donato Antonacci, Pasquale Crupi, et al.
Thrombosis and Haemostasis|April 8, 2006
Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysisBianca M Binetti, Crescenza Rotunno, Armando Tripodi, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysisMario Colucci, Bianca M Binetti, Maria G Branca, et al.
Blood Transfusion = Trasfusione Del Sangue|December 30, 2021
Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolismLavinia Dirienzo, Antonia Vitulli, Federica Mancazzo, et al.
Thrombosis Research|October 5, 2007
TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survivalPaolo Gresele, Bianca M Binetti, Giovanna Branca, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|October 29, 2020
A PPAR-α agonist protects the non-adrenergic, non-cholinergic inhibitory system of guinea pig trachea from the effect of inhaled ammonium persulphate: a pilot studyAntonio Dellabianca, Carolina Beretta, Marisa Faniglione, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 2020
FVIII/VWF complex displays a greater pro-haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell-based modelsConcetta T Ammollo, Fabrizio Semeraro, Antonia Vitulli, et al.
Journal of Thrombosis and Haemostasis : JTH|October 2, 2019
Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia AFabrizio Semeraro, Maria E Mancuso, Concetta T Ammollo, et al.
Toxicology and Applied Pharmacology|February 22, 2008
Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: another potential mechanism of immune-suppressionMaria R Rossiello, Crescenzia Rotunno, Addolorata Coluccia, et al.
Journal of Medicinal Chemistry|October 1, 2014
How a β-D-glucoside side chain enhances binding affinity to thrombin of inhibitors bearing 2-chlorothiophene as P1 moiety: crystallography, fragment deconstruction study, and evaluation of antithrombotic propertiesBenny D Belviso, Rocco Caliandro, Modesto de Candia, et al.
Pageof 5